Amlodipine/rosuvastatin/telmisartan - Ildong Pharmaceutical
Alternative Names: Amlodipine/telmisartan/rosuvastatin - Ildong Pharmaceutical; ID-TAR; Rosuvastatin/telmisartan/amlodipine- Ildong Pharmaceutical; TAR - Ildong Pharmaceutical; Telmisartan/amlodipine/rosuvastatin - Ildong Pharmaceutical; Telostop PlusLatest Information Update: 10 Sep 2018
At a glance
- Originator Ildong Pharmaceutical
- Class Antihyperlipidaemics; Antihypertensives; Benzimidazoles; Benzoates; Dihydropyridines; Fluorobenzenes; Ischaemic heart disorder therapies; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action ACE inhibitors; Angiotensin type 2 receptor antagonists; Calcium channel antagonists; Cytochrome P-450 enzyme system inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hyperlipidaemia; Hypertension
Most Recent Events
- 10 Sep 2018 Chemical structure information added
- 31 Aug 2018 IlDong Pharmaceutical plans a phase IV trial for Hypertension and Hyperlipidemia in South Korea (NCT03648801)
- 01 Aug 2018 Launched for Hyperlipidaemia in South Korea (PO) (IlDong Pharmaceutical pipeline, August 2018)